Opus Genetics, Inc.
Income Statement
| Line Item | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — | — | — | — |
| Cost of Revenue | — | $100.0K | — | — | — | — | — | — |
| Gross Profit | — | $-100.0K | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $3.9M | $3.2M | — | — | — | — | — | — |
| SG&A Expense | $6.0M | $2.9M | — | — | — | — | — | — |
| Operating Income | $-10.3M | $-6.5M | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | — | — | — | — | — | — |
| Net Income | $-14.0M | $-2.9M | $-3.7M | $-4.4M | $-6.5M | $-6.3M | $-3.3M | $-2.8M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $-0.03 | $-0.01 | — | — | — | — | — | — |
| EPS (Diluted) | $-0.03 | $-0.01 | — | — | — | — | — | — |
| Shares Outstanding (Basic) | 505.0M | — | — | — | — | — | — | — |
| Shares Outstanding (Diluted) | 505.0M | — | — | — | — | — | — | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |